Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Diseases and Conditions 2011h
The 10 mg/mL concentration creates a significant challenge for the starting dose
Close provider monitoring ensures dosing supports both weight management and training goals
Say goodbye to sleepless nights and discomfort
Coggan M, Whitbread L, Whittington A, Board P
Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity
US$ 20.45
US$ 29.06
US$ 21.09
US$ 21.86
US$ 27.73
US$ 20.63
US$ 26.25
US$ 24.42
US$ 25.44
US$ 22.23
US$ 26.38
US$ 29.88
US$ 25.53
US$ 22.74
